[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367673-105":59,"doc-detail-367673-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","curcumin-induces-homologous-recombination-deficiency-by-brca2-degradation-in-breast-cancer-and-normal-cells","Curcumin Induces Homologous Recombination Deficiency by BRCA2 Degradation in Breast Cancer and Normal Cells","","The study investigates how curcumin affects the homologous recombination (HR) DNA repair pathway in breast cancer and normal cells, with special attention to BRCA2 degradation. Background context covers breast cancer treatment advances, including PARP inhibitors (PARPi) effective in HR-deficient tumors, and the widespread use of herbal supplements by patients. Using multiple breast cancer cell lines, normal cell lines, and a breast cancer PDX model, curcumin reduced RAD51 ionizing-radiation-induced focus formation and decreased BRCA2 levels. Results indicate curcumin can induce HR deficiency in both cancerous and normal cells, increasing potential toxicity risk when combined with PARPi. Findings support cautious supplementation with extensive monitoring during PARPi therapy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/curcumin-induces-homologous-recombination-deficiency-by-brca2-degradation-in-breast-cancer-and-normal-cells/367673/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/curcumin-induces-homologous-recombination-deficiency-by-brca2-degradation-in-breast-cancer-and-normal-cells/367673.png","ImageObject",300,407,{"name":92,"@type":93},"Cart","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research question of the article?","Question",{"text":112,"@type":113},"The article examines whether curcumin can induce homologous recombination deficiency by causing BRCA2 degradation, and how that might affect responses to PARP inhibitor (PARPi) therapy in breast cancer and normal cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers assess DNA repair changes?",{"text":117,"@type":113},"They evaluated RAD51 ionizing-radiation-induced focus formation after treatment with curcumin, and they used BRCA2 Western blot analysis in selected breast cancer cell lines.",{"name":119,"@type":110,"acceptedAnswer":120},"What did the results show about curcumin’s effects on cells treated with PARPi?",{"text":121,"@type":113},"Curcumin reduced RAD51 focus formation capacity across tested models, decreased BRCA2 levels, and sensitized both cancerous and normal cells to PARPi, indicating a potential increased toxicity risk during combined use.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367673,1790198118,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},18829141979164,"https://eur-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Article  \nCurcumin Induces Homologous Recombination Deficiency by BRCA2 Degradation in Breast Cancer and Normal Cells  \nZofia M. Komar 1, Marjolijn M. Ladan 1,2, Nicole S. Verkaik 1,2, Ahmed Dahmani 3, Elodie Montaudon 3, Elisabetta Marangoni 3, Roland Kanaar 1,2, Julie Nonnekens 1,2,4, Adriaan B. Houtsmuller 5, Agnes Jager 6 and Dik C. van Gent 1,2, *  \nAcademic Editor: Nicola Curtin  \nReceived: 2 June 2025  \nRevised: 17 June 2025  \nAccepted: 20 June 2025  \nPublished: 24 June 2025  \nCitation: Komar, Z.M.; Ladan, M.M.; Verkaik, N.S.; Dahmani, A.; Montaudon, E.; Marangoni, E.; Kanaar, R.; Nonnekens, J.; Houtsmuller, A.B.; Jager, A.; et al. Curcumin Induces Homologous Recombination Deficiency by BRCA2 Degradation in Breast Cancer and Normal Cells. Cancers 2025, 17, 2109. [https://](https://)[ ](https://)[doi.org/10.3390/cancers17132109](doi.org/10.3390/cancers17132109)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Department of Molecular Genetics, Erasmus Medical Center Cancer Institute, University Medical Center, 3015CN Rotterdam, The Netherlands  \n2 Oncode Institute, 3521 Utrecht, The Netherlands  \n3 Translational Research Department, Institut Curie, Paris Sciences et Lettres University, 75005 Paris, France  \n4 Department of Radiology and Nuclear Medicine, Erasmus Medical Center Cancer Institute, University Medical Center, 3015CN Rotterdam, The Netherlands  \n5 Erasmus Optical Imaging Center and Department of Pathology, Erasmus Medical Center, 3015CN Rotterdam, The Netherlands  \n6 Department of Medical Oncology, Erasmus Medical Center Cancer Institute, University Medical Center, 3015CN Rotterdam, The Netherlands  \n* Correspondence: [d.vangent@erasmusmc.nl](d.vangent@erasmusmc.nl); Tel.: +31-107043932  \nSimple Summary  \nMany breast cancer patients seek supplementation on top of the conventional anti-cancer treatment, in the hope that it will help shrink their tumors. Curcumin is an example of such a supplement, often used by cancer patients due to the wide range of its health claims. Interestingly, recent research has shown that curcumin can also affect an important DNA repair pathway—homologous recombination (HR) . Therefore, our study aimed to determine the potential effect of curcumin combined with a breast cancer therapy that is effective in HR deficient tumors, Poly (ADP-ribose) polymerase inhibitor (PARPi) . We showed that curcumin treatment sensitized not only the cancerous but also the normal cells to PARPi treatment, suggesting that curcumin supplementation in patients undergoing PARPi therapy should be approached with caution.  \nAbstract  \nBackground: Breast cancer (BC) is the most common cancer in women worldwide. Much progress has been made to improve treatment options for patients suffering from the disease, including a novel therapy—Poly (ADP-ribose) polymerase inhibitor (PARPi) that specifically targets tumors with deficiencies in the Homologous Recombination (HR) DNA repair pathway. To benefit better from conventional therapy, many patients seek alternative supplementation, with 20–30% of cancer patients using herbal medication on top of their regular treatment. An example of such easily available over-the-counter supplements iscurcumin, a natural compound derived from turmeric (Curcuma longa) . Various studies reported the potential HR deficiency (HRD) inducing effect of curcumin in cancer cells. Methods: Eight BrC and three normal cell lines and a BrC PDX model were used to evaluate the effect of curcumin on RAD51 ionizing radiation-induced focus (IRIF) formation. Three breast BrC cell lines underwent further analysis using the BRCA2 Western blot technique. To assess cell survival after treatment with curc","cbCaiuiYRg2pe0ky","https://ap.wps.com/l/cbCaiuiYRg2pe0ky","pdf",15691872,14,"English","# Abstract\n# Simple Summary\n# Keywords\n# 1. Introduction","[{\"question\":\"What is the main research question of the article?\",\"answer\":\"The article examines whether curcumin can induce homologous recombination deficiency by causing BRCA2 degradation, and how that might affect responses to PARP inhibitor (PARPi) therapy in breast cancer and normal cells.\"},{\"question\":\"How did the researchers assess DNA repair changes?\",\"answer\":\"They evaluated RAD51 ionizing-radiation-induced focus formation after treatment with curcumin, and they used BRCA2 Western blot analysis in selected breast cancer cell lines.\"},{\"question\":\"What did the results show about curcumin’s effects on cells treated with PARPi?\",\"answer\":\"Curcumin reduced RAD51 focus formation capacity across tested models, decreased BRCA2 levels, and sensitized both cancerous and normal cells to PARPi, indicating a potential increased toxicity risk during combined use.\"}]","Curcumin Induces Homologous Recombination Deficiency by BRCA2 Degradation in Breast Cancer and Normal Cells | PDF",1790171911,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ba46c5e35d658fbacc18666c5a05c604.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e33d1d7ff1ae2393939beaced6796832.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8742afae4527ca3288a719fe8d5c5a51.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f64dcebf336d2cf37232d7612443fd8.webp",980,1385]